CME Information
Provider Statement:
This continuing medical education activity is provided by 
This continuing education activity is provided by 
Support Statement: This activity is supported by an educational grant from Shire.
Target Audience: The intended audience for this activity is ophthalmologists, optometrists, and other health care professionals involved in the treatment of patients with ocular surface disorders.
Learning Objectives:
- Evaluate risk factors and diagnostic modalities for ocular surface disease to facilitate prompt identification and diagnosis.
- Describe the effects that ocular surface disease is known to have on surgical outcomes.
- Assess treatment strategies that provide optimal outcomes according to the etiology and severity of the ocular surface disease.
Chief Medical Editor
Terry Kim, MD
Professor of Ophthalmology
Duke University School of Medicine
Chief, Cornea and External Disease Division
Director, Refractive Surgery Service
Duke University Eye Center
Durham, NC
Associate Medical Editor
Paul M. Karpecki, OD, FAAO
Director, Cornea Services
Kentucky Eye Institute
Lexington, KY
Editorial Board and Faculty Contributors
Brandon D. Ayres, MD
Cornea Service
Co-Director of Cornea Fellowship
Wills Eye Hospital
Philadelphia, PA
Kenneth A. Beckman, MD, FACS
Director, Corneal Service
Comprehensive EyeCare of Central Ohio
Clinical Assistant Professor
The Ohio State University
Westerville, OH
Marjan Farid, MD
Associate Professor of Ophthalmology
Director of Cornea, Cataract and Refractive Surgery
Gavin Herbert Eye Institute
University of California, Irvine
Irvine, CA
Preeya K. Gupta, MD
Associate Professor of Ophthalmology
Cornea, Cataract, and Refractive Surgery
Duke University Eye Center
Durham, NC
Reviewers
Steve Abel, PharmD, FASHP
Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP
Medical Writer
Valerie Zimmerman, PhD
Accreditation:
Purdue University is approved by the Council on Optometric Practitioner Education (COPE) as an administrator/provider of continuing education (CE).
Vindico Medical Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Credit Designation:
This enduring material is COPE-accredited for 1.0 continuing education credits and is approved for one (1) year from the date of original release, December 1, 2018 to December 1, 2019.
COPE ID #: 60222-AS
COPE Event #: 116655
Please consult your state’s Board of Optometry to determine if the CE credit may apply toward your CE requirement for license renewal.
Vindico Medical Education designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
How to Participate in This Activity and Obtain CE/CME Credit:
To participate in this CE/CME activity, you must read the objectives, answer the pretest questions, read the articles, and complete the posttest and evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering 70% of the posttest questions correctly. Upon receipt of the completed materials, if a satisfactory score on the posttest is achieved, Purdue University will issue a CE Certificate or Vindico Medical Education will issue an AMA PRA Category (1) Credit(s)™ certificate.
Disclosures:
In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support, all CME providers are required to disclose to the activity audience the relevant financial relationships of the planners, reviewers, teachers, and authors involved in the development of CME content. An individual has a relevant financial relationship if he or she has a financial relationship in any amount occurring in the last 12 months with a commercial interest whose products or services are discussed in the CME activity content over which the individual has control.
Editorial Board/Faculty report the following relationship(s):
Brandon D. Ayres, MD
Consulting Fee: Alcon, Allergan, Avedro, CorneaGen, MicroSurgical Technology, Omeros
Speakers Bureau: Alcon, Allergan, Shire
Kenneth A. Beckman, MD, FACS
Royalty: Holbar Medical Products
Consulting Fee: Alcon, Allergan, Avedro, Bausch + Lomb, Bruder, Mallinckrodt, ReFocus, Shire, Sun, TearLab
Speakers Bureau: Alcon, Allergan, Bausch + Lomb, Shire
Contracted Research: Avedro, ICare, Kala
Ownership Interest: Calhoun, Ocular Science, RPS
Marjan Farid, MD
Consulting Fee: Allergan, Bio-Tissue, CorneaGen, Johnson & Johnson Vision, Kala, Shire
Preeya K. Gupta, MD
Consulting Fee: Alcon, Allergan, Aurea, Bio-Tissue, Johnson & Johnson Vision, Kala, NovaBay, Ocular Science, Shire, TearLab, TearScience, Zeiss
Paul M. Karpecki, OD, FAAO
Consulting Fee: Alcon, Allergan, Akorn, Avellino, Bausch + Lomb/Valeant, Beaver-Visitec, Bio-Tissue, BlephEx, Bruder Healthcare, Cambium Pharma, eyeBrain, EyeGate, Focus Labs, Imprimis, Johnson & Johnson Vision, Oasis Medical, Oculus, OCuSOFT, Rendia, ScienceBased Health, Shire, Sight Sciences, Silk Technologies, Sun, Tear Film Innovations, TearLab, TelScreen, Topcon
Contracted Research: Research Principal Investigator: Olympic Ophthalmics, Shire, Sight Sciences
Ownership Interest: Bruder Healthcare, Optometric Medical Solutions
Terry Kim, MD
Consulting Fee: Acucela, Aerie, Alcon/Novartis, Allergan/Actavis, Avedro, Avellino Labs, Bausch + Lomb/Valeant, BlephEx, CoDa/Ocunexus Therapeutics, Kala, NovaBay, Ocular Therapeutix, Omeros, PowerVision, Presbyopia Therapies, Shire, SightLife Surgical, Simple Contacts, TearLab, TearScience
Ownership Interest: Kala, NovaBay, Ocular Therapeutix, Omeros, SightLife Surgical, Simple Contacts, TearScience
Reviewers report the following relationship(s):
Steve Abel, PharmD, FASHP
Advisory Board Member: Central Indiana Jefferson Foundation Board, ESN Board representing Purdue President Daniels, TechPoint Board
Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP
No relevant financial relationships to disclose.
Medical Writer reports the following relationship(s):
Valerie Zimmerman, PhD
No relevant financial relationships to disclose.
Purdue University and Vindico Medical Education staff report the following relationships:
No relevant financial relationships to disclose.
Signed disclosures are on file at Purdue University and Vindico Medical Education, Office of Medical Affairs and Compliance.
Unlabeled and Investigational Usage:
The audience is advised that this continuing medical education activity may contain references to unlabeled uses of US Food and Drug Administration (FDA)-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non FDA-approved or investigational use of products/devices.
Copyright Statement:
Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680. Printed in the USA. Copyright © 2018 Vindico Medical Education. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any of Purdue University and Vindico Medical Education continuing education activities does not necessarily reflect the views and opinions of Purdue University and Vindico Medical Education. Neither Purdue University and Vindico Medical Education nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the US Food and Drug Administration. All readers and continuing education participants should verify all information before treating patients or utilizing any product.
CME/COPE Questions?
Contact us at:
Purdue University: cmemda@purdue.edu or 765-496-1306
Vindico Medical Education: cme@vindicocme.com or 856-994-9400, ext. 504